Tobacco product labeling system

Abstract

The disclosed invention relates to visual content indicators of a tobacco product. More specifically, the invention includes labeling systems that provide at least one visual indicator of a tobacco product, methods for using the systems, and tobacco products that display one or more visual indicators of content. The present invention generally relates to tobacco products, which have a reduced amount of nicotine and tobacco specific nitrosamines (TSNAs), and contain one or more nicotine substitutes. The use of these tobacco products to reduce the exposure of an individual to nicotine, as well as, facilitating tobacco-use cessation is disclosed.

1 . A tobacco product that comprises a tobacco with a reduced amount of nicotine, a collective content of N′-nitrosonornicotine (NNN), N′-nitrosoanatabine (NAT), N′-nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) of less than about 2.0 μg/g, and a nicotine substitute.  
   
   
       2 . The tobacco product of  claim 1 , wherein said tobacco product is labeled with a visual content indicator.  
   
   
       3 . A smoking cessation kit that comprises the tobacco product of  claim 1 .  
   
   
       4 . (canceled)  
   
   
       5 . The tobacco product of  claim 1 , wherein said tobacco is genetically modified.  
   
   
       6 . The smoking cessation kit of  claim 3 , wherein said tobacco product is genetically modified.  
   
   
       7 . The tobacco product of  claim 1 , wherein said reduced amount of nicotine is 0.6 mg/g or less.  
   
   
       8 . The tobacco product of  claim 1 , wherein said reduced amount of nicotine is 0.3 mg/g or less.  
   
   
       9 . The tobacco product of  claim 1 , wherein said reduced amount of nicotine is 0.05 mg/g or less.  
   
   
       10 . The tobacco product of  claim 1 , wherein said nicotine substitute is cystine.  
   
   
       11 . The tobacco product of  claim 2 , wherein said visual content indicator indicates the amount of nicotine in the tobacco product.  
   
   
       12 . The tobacco product of  claim 2 , wherein said visual content indicator indicates the amount of nicotine substitute in the tobacco product.  
   
   
       13 . The smoking cessation kit of  claim 3 , wherein said reduced amount of nicotine is 0.6 mg/g or less.  
   
   
       14 . The smoking cessation kit of  claim 3 , wherein said reduced amount of nicotine is 0.3 mg/g or less.  
   
   
       15 . The smoking cessation kit of  claim 3 , wherein said reduced amount of nicotine is 0.05 mg/g or less.  
   
   
       16 . The smoking cessation kit of  claim 3 , wherein said nicotine substitute is cystine.  
   
   
       17 . The smoking cessation kit of  claim 3 , wherein said tobacco product comprises visual content indicator that indicates the amount of nicotine in the tobacco product.  
   
   
       18 . The smoking cessation kit of  claim 3 , wherein said tobacco product comprises a visual content indicator that indicates the amount of nicotine substitute in the tobacco product.  
   
   
       19 . A smoking cessation kit comprising a first cigarette that comprises a tobacco with a reduced amount of nicotine, a collective content of N′-nitrosonornicotine (NNN), N′-nitrosoanatabine (NAT), N′-nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-3-pyridyl)-1-butanone (NNK) of less than about 2.0 μg/g, and a nicotine substitute and a second cigarette that comprises tobacco with a reduced amount of nicotine, a collective content of N′-nitrosonornicotine (NNN), N′-nitrosoanatabine (NAT), N′-nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) of less than about 2.0 μg/g, and a nicotine substitute, wherein said second cigarette comprises less nicotine than the first cigarette.  
   
   
       20 . The smoking cessation kit of  claim 19 , further comprising a third cigarette with a reduced amount of nicotine, a collective content of N′-nitrosonornicotine (NNN), N′-nitrosoanatabine (NAT), N′-nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) of less than about 2.0 μg/g, and a nicotine substitute, wherein said third cigarette comprises less nicotine than said first or second cigarettes.  
   
   
       21 . The smoking cessation kit of  claim 19 , wherein said reduced amount of nicotine is 0.6 mg/g or less.  
   
   
       22 . The smoking cessation kit of  claim 19 , wherein said reduced amount of nicotine is 0.3 mg/g or less.  
   
   
       23 . The smoking cessation kit of  claim 19 , wherein said reduced amount of nicotine is 0.05 mg/g  
   
   
       24 . The smoking cessation kit of  claim 19 , wherein said nicotine substitute is cystine.  
   
   
       25 . The smoking cessation kit of  claim 19 , wherein said tobacco product comprises visual content indicator that indicates the amount of nicotine in the tobacco product.  
   
   
       26 . The smoking cessation kit of  claim 19 , wherein said tobacco product comprises a visual content indicator that indicates the amount of nicotine substitute in the tobacco product.  
   
   
       27 . A method of reducing the exposure of a tobacco user to nicotine comprising 
 identifying a tobacco user for a reduction in exposure to nicotine; and    providing said tobacco user the smoking cessation kit of  claim 3 .    
   
   
       28 . A method of reducing the exposure of a tobacco user to nicotine comprising 
 identifying a tobacco user for a reduction in exposure to nicotine; and    providing said tobacco user the smoking cessation kit of  claim 19.